These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Three phases of immunologic unresponsiveness following liver grafting in rats. Hasuike Y; Monden M; Valdivia LA; Kubota N; Kanai T; Gotoh M; Okamura J; Mori T Transplant Proc; 1987 Feb; 19(1 Pt 1):457-8. PubMed ID: 3274805 [No Abstract] [Full Text] [Related]
7. Small bowel transplantation in sensitized recipients: comparison with heart, kidney, and liver grafts. Murase N; Fujisaki S; Tanabe M; Tsamandas AC; Todo S; Starzl TE; Demetris AJ Transplant Proc; 1994 Jun; 26(3):1517-8. PubMed ID: 7518139 [No Abstract] [Full Text] [Related]
8. Xenogeneic liver transplantation: its influence on secondary allogeneic graft rejection. Chiche L; Bittard H; Adam R; Castaing D; Bismuth H Transplant Proc; 1990 Oct; 22(5):2333-4. PubMed ID: 2219395 [No Abstract] [Full Text] [Related]
9. Microchimerism and graft acceptance: V. Rat liver allograft acceptance. Miyahara T; Yokoi Y; Hara MH; Nakamura S; Baba S; Shibata K; Koga Y; Suzuki H; Yamashita A; Miyamoto M; Li XK; Suzuki S; Amemiya H; Iwaya M; Yamaguchi A; Yoshimasu H; Kimura H Transplant Proc; 1996 Jun; 28(3):1291-2. PubMed ID: 8658664 [No Abstract] [Full Text] [Related]
10. A new immunosuppressive drug, brequinar sodium, suppresses liver allograft rejection in the rat. Knoop M; Cramer DV; Chapman FC; Makowka L Transplant Proc; 1993 Aug; 25(4):2697-8. PubMed ID: 8356719 [No Abstract] [Full Text] [Related]
11. Effect of primary xenograft or allograft on the rejection of a subsequent allograft. Tchervenkov CI; Shum-Tim D; Serrick CJ; Gyopar A; Lough JO; Tchervenkov JI Transplant Proc; 1993 Feb; 25(1 Pt 1):453-4. PubMed ID: 8438376 [No Abstract] [Full Text] [Related]
12. Intraportal injection of specific allogeneic cells can prolong neonatal intestinal free graft survival. Lee SK; Perez-Atayde A; Takeda T; Vacanti JP; Lund DP Transplant Proc; 1994 Jun; 26(3):1579-80. PubMed ID: 8030044 [No Abstract] [Full Text] [Related]
13. Effect of selective depletion of natural killer cells on allograft rejection. Markus PM; van den Brink M; Cai X; Harnaha J; Palomba L; Hiserodt JC; Cramer DV Transplant Proc; 1991 Feb; 23(1 Pt 1):178-9. PubMed ID: 1990508 [No Abstract] [Full Text] [Related]
14. Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: the distribution of donor class I-positive cells in the recipient. Goto M; Yamaguchi Y; Matsuno K; Takata N; Makino Y; Kikuchi N; Hamaguchi H; Hisama N; Otsuka Y; Mori K Transplant Proc; 1993 Apr; 25(2):1893-5. PubMed ID: 8470217 [No Abstract] [Full Text] [Related]
15. Microchimerism and graft acceptance: split tolerance in skin and cardiac transplantation with minor histocompatibility antigen H-Y differences. Suzuki H; Hara MH; Yamashita A; Miyamoto M; Shibata K; Koga Y; Iwaya M; Yokoi Y; Yamaguchi A; Masaki Y; Li XK; Suzuki S; Amemiya H; Kimura H Transplant Proc; 1996 Jun; 28(3):1262-3. PubMed ID: 8658651 [No Abstract] [Full Text] [Related]
16. Induction of donor-specific hyporeactivity in augmented microchimerism in rat liver transplantation followed by donor bone marrow. Tashiro H; Fukuda Y; Kimura A; Hoshino S; Shintaku S; Ohdan H; Miyata H; Dohi K Transplant Proc; 1997; 29(1-2):1196-7. PubMed ID: 9123269 [No Abstract] [Full Text] [Related]
17. In vivo evidence for the Th1/Th2 paradigm: oral alloantigen-induced modulation of accelerated allograft rejection is associated with dense intragraft IL-4. Hancock WW; Sayegh MH; Carpenter CB Transplant Proc; 1992 Oct; 24(5):2313-4. PubMed ID: 1413074 [No Abstract] [Full Text] [Related]
18. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier. Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371 [TBL] [Abstract][Full Text] [Related]